Literature DB >> 19900403

Persistent induction of cytochrome P450 (CYP)1A enzymes by 3-methylcholanthrene in vivo in mice is mediated by sustained transcriptional activation of the corresponding promoters.

Weiwu Jiang1, Lihua Wang, Weisheng Zhang, Richard Coffee, Inayat S Fazili, Bhagavatula Moorthy.   

Abstract

There is significant human exposure to polycyclic aromatic hydrocarbons (PAHs), many of which are potent carcinogens. Cytochrome P450 (CYP)1A enzymes play key roles in the metabolic activation of PAHs to carcinogenic metabolites. We previously showed persistent induction of CYP1A enzymes by 3-methylcholanthrene (MC) in vivo in rodents. In this study, we tested the hypothesis that MC elicits persistent induction of CYP1A1 and 1A2 in vivo by mechanisms entailing sustained transcriptional activation of the corresponding promoters. Adult male wild type (WT) (Cd-1) mice, transgenic mice expressing the human CYP1A1 promoter or the mouse CYP1A2 promoter were treated with the vehicle corn oil (CO) or the carcinogenic PAH, 3-methylcholanthrene (MC), once daily for 4days, and luciferase reporter gene expression was determined at 1, 8, 15, and 22days after MC withdrawal by bioluminescent imaging. Pulmonary and hepatic endogenous expression of CYP1A1 and 1A2 was also determined at the enzymatic, protein, and mRNA levels. The major findings were that MC elicited marked enhancement in the luciferase expression in the CYP1A1-luc as well CYP1A2-luc transgenic mice that was sustained for up to 22days, the magnitude of induction being more pronounced in the CYP1A1-luc mice. MC also caused persistent induction of endogenous CYP1A1 and 1A2 expression in the WT, CYP1A1-luc, and 1A2-luc mice for up to 22days. In conclusion, our results support the hypothesis that MC elicits sustained CYP1A1 and 1A2 expression by sustained transcriptional activation of the corresponding promoters. Thus, these novel transgenic models should be very useful for further understanding of the molecular mechanisms of persistent CYP1A induction, in relation to PAH-mediated carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19900403      PMCID: PMC2787915          DOI: 10.1016/j.bbrc.2009.11.021

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Functional involvement of the Brahma/SWI2-related gene 1 protein in cytochrome P4501A1 transcription mediated by the aryl hydrocarbon receptor complex.

Authors:  Song Wang; Oliver Hankinson
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

2.  3-Methylcholanthrene elicits DNA adduct formation in the CYP1A1 promoter region and attenuates reporter gene expression in rat H4IIE cells.

Authors:  Bhagavatula Moorthy; Kathirvel Muthiah; Inayat S Fazili; Sudha R Kondraganti; Lihua Wang; Xanthi I Couroucli; Weiwu Jiang
Journal:  Biochem Biophys Res Commun       Date:  2007-01-26       Impact factor: 3.575

3.  Persistent expression of 3-methylcholanthrene-inducible cytochromes P4501A in rat hepatic and extrahepatic tissues.

Authors:  B Moorthy
Journal:  J Pharmacol Exp Ther       Date:  2000-07       Impact factor: 4.030

4.  3-Methylcholanthrene-inducible hepatic DNA adducts: a mechanistic hypothesis linking sequence-specific DNA adducts to sustained cytochrome P4501A1 induction by 3-methylcholanthrene.

Authors:  Bhagavatula Moorthy
Journal:  Redox Rep       Date:  2002       Impact factor: 4.412

5.  Persistent induction of hepatic and pulmonary phase II enzymes by 3-methylcholanthrene in rats.

Authors:  Sudha R Kondraganti; Weiwu Jiang; Anil K Jaiswal; Bhagavatula Moorthy
Journal:  Toxicol Sci       Date:  2008-01-17       Impact factor: 4.849

6.  The role of the dioxin-responsive element cluster between the Cyp1a1 and Cyp1a2 loci in aryl hydrocarbon receptor biology.

Authors:  Manabu Nukaya; Susan Moran; Christopher A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

7.  AHR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines.

Authors:  Sarah L Hockley; Volker M Arlt; Daniel Brewer; Robert Te Poele; Paul Workman; Ian Giddings; David H Phillips
Journal:  Chem Res Toxicol       Date:  2007-10-19       Impact factor: 3.739

8.  Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements.

Authors:  Kouichi Yoshinari; Rika Ueda; Kazutomi Kusano; Tsutomu Yoshimura; Kiyoshi Nagata; Yasushi Yamazoe
Journal:  Biochem Pharmacol       Date:  2008-04-16       Impact factor: 5.858

9.  HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation.

Authors:  Michael Schnekenburger; Li Peng; Alvaro Puga
Journal:  Biochim Biophys Acta       Date:  2007-07-20

Review 10.  Role of cAMP in mediating AHR signaling.

Authors:  Barbara Oesch-Bartlomowicz; Franz Oesch
Journal:  Biochem Pharmacol       Date:  2008-11-01       Impact factor: 5.858

View more
  8 in total

1.  Disruption of the gene for CYP1A2, which is expressed primarily in liver, leads to differential regulation of hepatic and pulmonary mouse CYP1A1 expression and augmented human CYP1A1 transcriptional activation in response to 3-methylcholanthrene in vivo.

Authors:  Weiwu Jiang; Lihua Wang; Sudha R Kondraganti; Inayat S Fazili; Xanthi I Couroucli; Edward A Felix; Bhagavatula Moorthy
Journal:  J Pharmacol Exp Ther       Date:  2010-08-23       Impact factor: 4.030

2.  Augmented oxygen-mediated transcriptional activation of cytochrome P450 (CYP)1A expression and increased susceptibilities to hyperoxic lung injury in transgenic mice carrying the human CYP1A1 or mouse 1A2 promoter in vivo.

Authors:  Weiwu Jiang; Xanthi I Couroucli; Lihua Wang; Roberto Barrios; Bhagavatula Moorthy
Journal:  Biochem Biophys Res Commun       Date:  2011-03-06       Impact factor: 3.575

Review 3.  Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.

Authors:  Bhagavatula Moorthy; Chun Chu; Danielle J Carlin
Journal:  Toxicol Sci       Date:  2015-05       Impact factor: 4.849

4.  Persistent induction of cytochrome P4501A1 in human hepatoma cells by 3-methylcholanthrene: evidence for sustained transcriptional activation of the CYP1A1 promoter.

Authors:  Inayat S Fazili; Weiwu Jiang; Lihua Wang; Edward A Felix; Tanvir Khatlani; Xavier Coumoul; Robert Barouki; Bhagavatula Moorthy
Journal:  J Pharmacol Exp Ther       Date:  2010-01-05       Impact factor: 4.030

5.  Hyperoxia-mediated transcriptional activation of cytochrome P4501A1 (CYP1A1) and decreased susceptibility to oxygen-mediated lung injury in newborn mice.

Authors:  Weiwu Jiang; Paramahamsa Maturu; Yanhong Wei Liang; Lihua Wang; Krithika Lingappan; Xanthi Couroucli
Journal:  Biochem Biophys Res Commun       Date:  2017-10-31       Impact factor: 3.575

6.  Neuronal programming by microbiota regulates intestinal physiology.

Authors:  Brigitta Stockinger; Andrew J Macpherson; Vassilis Pachnis; Yuuki Obata; Álvaro Castaño; Stefan Boeing; Ana Carina Bon-Frauches; Candice Fung; Todd Fallesen; Mercedes Gomez de Agüero; Bahtiyar Yilmaz; Rita Lopes; Almaz Huseynova; Stuart Horswell; Muralidhara Rao Maradana; Werend Boesmans; Pieter Vanden Berghe; Andrew J Murray
Journal:  Nature       Date:  2020-02-05       Impact factor: 49.962

7.  Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma.

Authors:  Munirah Ahmad; Shazlan-Noor Suhaimi; Tai-Lin Chu; Norazlin Abdul Aziz; Noor-Kaslina Mohd Kornain; D S Samiulla; Kwok-Wai Lo; Chew-Hee Ng; Alan Soo-Beng Khoo
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

8.  The transformics assay: first steps for the development of an integrated approach to investigate the malignant cell transformation in vitro.

Authors:  Maria Grazia Mascolo; Stefania Perdichizzi; Monica Vaccari; Francesca Rotondo; Cristina Zanzi; Sandro Grilli; Martin Paparella; Miriam N Jacobs; Annamaria Colacci
Journal:  Carcinogenesis       Date:  2018-07-03       Impact factor: 4.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.